Podiatrists in South Ogden, UT Accepting Medicare
6 Podiatrists found. Showing 1 - 6
 Utah Podiatry Group Pc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 962 Chambers St, South Ogden, UT 84403 Phone: 801-373-2499 Fax: 801-373-5200 |
Wasatch Foot & Ankle Institute Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 955 Chambers St, Suite 200, South Ogden, UT 84403 Phone: 801-627-2122 |
 Dr. Colby H Frost, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 955 Chambers St Ste 200, South Ogden, UT 84403 Phone: 801-627-2122 Fax: 801-627-2125 |
Mark Edwin Woolley, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 955 Chambers St Ste 200, South Ogden, UT 84403 Phone: 801-409-2100 Fax: 801-475-6169 |
Dr. Jason D Campbell, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 955 Chambers St Ste 200, South Ogden, UT 84403 Phone: 801-627-2122 Fax: 801-627-2125 |
The Foot And Ankle Health Center, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 955 Chambers St Ste 200, South Ogden, UT 84403 Phone: 801-409-2100 Fax: 801-475-6169 |
News Archive
Study clears potential barrier to controlling mosquito-borne diseases
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 "gene drive" technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika.
Adequate intake of choline essential for good health and physical performance
Athletes and physically active people of all ages can benefit from choline not only for their overall health, but also because it supports muscle performance during exercise, and can improve stamina.
'First-in-man' clinical trial protocols often not guided by pharmacology, analysis shows
A new analysis published in the British Journal of Clinical Pharmacology indicates that 'first-in-man' clinical trial protocols in the Netherlands often lack a consistent consideration of pharmacokinetic and pharmacodynamic aspects in establishing drug doses.
Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer
Aeterna Zentaris Inc., today announced positive interim data for the Phase 1 portion of its ongoing Phase 1/2 study in castration and taxane-resistant prostate cancer with its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108.
Anticancer drug Cisplatin induces side effects
Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists, mostly from CNRS and the Université de Nice has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained.
› Verified 8 days ago
Chiropractors
Physical Therapists
Podiatrists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Audiologists